AB

Ananta Basudev Behera

Active Director Additional Director DIN 10538808
DIN 10538808 First appointment Mar 2024 Primary industry Trading
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Ananta Basudev Behera

Data last updated:

Ananta Basudev Behera is an Additional Director at Saarix Pharma Private Limited (since 2024). The company operates in Trading.

DIN 10538808
Primary Designation Additional Director
Industry Trading
First Appointment 11 Mar 2024
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Saarix Pharma Private Limited U51909OR2021PTC037100
Additional Director11 Mar 20242021Active

Board colleagues of Ananta Basudev Behera

NameDINCompanyDesignation
Vaani Sachdeva09495300Saarix Pharma Private LimitedAdditional Director

Directorship timeline

Open interactive timeline →
Saarix Pharma Private Limited
Premium access

Shareholding and investment profile for Ananta Basudev Behera

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ananta Basudev Behera

Ananta Basudev Behera currently holds 1 directorship: Saarix Pharma Private Limited (Additional Director, since 11 Mar 2024).

Ananta Basudev Behera was first appointed on 11 Mar 2024 as Additional Director at Saarix Pharma Private Limited.

The current boards of Ananta Basudev Behera's companies include Vaani Sachdeva (Saarix Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available